Skip to main content
. 2016 Nov 15;7(52):86134–86147. doi: 10.18632/oncotarget.13348

Figure 2.

Figure 2

Percentage of specimens exhibiting low or high Gli1 expression and association of Gli1 with Foxm1 in CRC tumor specimens. ***P < 0.001. (B) Gli1 expression levels were measured by qRT-PCR. (C) The invasive capacity was determined by invasion assays. (D) Correlation between the mRNA expression level of Gli1 and Foxm1, (E) Gli1 expression level and CRC cells invasive capacity, (F) Foxm1 expression level and CRC cells invasive capacity analysed by Spearman's correlation test. (G) RNA and protein levels of Gli1 and Foxm1 in SCR, shGli1 cells and (H) SCRF, shFoxm1 cells. *p < 0.05, **p < 0.01, ***P < 0.001.